Research News and Research

RSS

Liberals agitated by compromise, but appear to back health reform

Politico reports that liberals are accruing a long list of reasons to be upset about the health reform negotiations: "A single-payer plan, a public option, a state 'opt-out' of the public option, a trigger and a Medicare buy-in — all ideas pushed by Democrats and blessed by [President] Obama at various times but now gone from the bill."

16 Dec 2009

Ivy Foundation awards nearly $10M for new patient-focused brain cancer research projects

Today, the Ben and Catherine Ivy Foundation (Ivy Foundation), announced that it is funding roughly $10 million for four new patient-focused research projects. As with all Ivy Foundation awards, these projects focus on improving the survival and quality of life for people with brain tumors but also specifically address new strategies to improve treatment development.

16 Dec 2009

Poll: Public cooling to health reform as debate drags on

"As the Senate struggles to meet a self-imposed, year-end deadline to complete work on legislation to overhaul the nation's health-care system, a new Washington Post-ABC News poll finds the public generally fearful that a revamped system would bring higher costs while worsening the quality of their care," The Washington Post reports. "A bare majority of Americans still believe government action is needed to control runaway health-care costs and expand coverage to the roughly 46 million people without insurance."

16 Dec 2009

Tea Party protestors rally against health bills at Capitol protest

The most vocal opponents of the health bills, Tea Party protestors, took to the Capitol yesterday.

16 Dec 2009

Immigrants lose lawsuit against hospital in Atlanta

"Efforts to force the public hospital [in Atlanta, Ga.] to continue providing free dialysis treatment to a group of immigrants, most of them illegal, suffered a setback on Tuesday when a judge dismissed a lawsuit challenging the recent closing of the hospital's outpatient renal clinic," The New York Times reports.

16 Dec 2009

EMD Serono, Brigham and Women's Hospital collaborate in MS research

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced a strategic collaboration with Brigham and Women's Hospital in Boston, to advance basic and clinical research in multiple sclerosis (MS), with the goal of generating new and innovative discoveries that advance treatment for people living with this condition. The multi-faceted agreement will run for up to 5 years, with the potential to renew the alliance thereafter. Both parties decided not to disclose financial details.

16 Dec 2009

Keryx Biopharmaceuticals initiates Phase 3 registration clinical trial for perifosine

Æterna Zentaris Inc., a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the initiation, by its partner Keryx Biopharmaceuticals Inc., of a Phase 3 registration clinical trial for perifosine (KRX-0401), the Company's PI3K/Akt pathway inhibitor, in relapsed/refractory multiple myeloma patients.

16 Dec 2009

Amendment to allow drug importation fails in Senate

A bipartisan plan to allow Americans to buy cheaper prescription drugs from suppliers in other countries, such as Canada, failed Tuesday in the Senate. The Wall Street Journal reports the two top supporters of the plan, Sens. Byron Dorgan, D-N.D., and John McCain, R-Ariz., said shopping overseas via the Internet and mail-order companies could save consumers up to $80 billion over a decade if their amendment were added to the health overhaul legislation.

16 Dec 2009

Xencor's initiation of novel monoclonal antibody human clinical trial triggers milestone payment from Pfizer

Xencor, Inc., a company using Fc engineering for the discovery and development of next-generation antibodies, announced today that the Company received a milestone payment from Pfizer Inc. The amount of the payment was not disclosed. The payment was triggered by the initiation of human clinical trials of a novel monoclonal antibody therapeutic that was optimized using Xencor technologies under a March 2009 technology license agreement.

16 Dec 2009

Encouraging early clinical results for treatment of KC with Avedro's Keraflex KXL technology

During the 5th International Congress of Corneal Cross Linking for Keratoconus in Leipzig, Germany on December 5th, Avedro presented encouraging early clinical results for treating keratoconus, a progressive disease of the cornea of the eye. The procedure, known as Keraflex® KXL, is non-incisional and reshapes the cornea without removing any tissue.

16 Dec 2009

Reprints Desk signs distribution deals with seven STM journal publishers

Derycz Scientific, Inc., a company that is pioneering a fresh way of facilitating the flow of information from content publishers to enterprise customers and their constituents, today announced that wholly-owned subsidiary Reprints Desk, Inc. has signed distribution deals with seven additional scientific, technical and medical (STM) journal publishers, expanding the pay-per-view content available to Reprints Desk customers and enhancing the speed of delivery.

16 Dec 2009

First Edition: December 16, 2009

Kaiser Health News staff writer Mary Agnes Carey explores some of the key issues within current health reform proposals related to Medicare and cost. "In an effort to rein in health costs, Senate Democrats are proposing steps that would give federal agencies more power to overhaul how Medicare pays for medical care - and thus reduce Congress' own role in running the giant program for the elderly" (Kaiser Health News).

16 Dec 2009

Pomegranate rind, metal salts and Vitamin C: An effective combination for treating MRSA infection

Pomegranates have already been hailed as a super-food but a team of scientists from Kingston University in South West London has found a new use for the deep red fruit. The team, led by Professor Declan Naughton, has discovered that the rind can be turned into an ointment for treating MRSA and other common hospital infections.

16 Dec 2009

Roche's P2X3 receptor program for chronic pain licensed to Afferent Pharmaceuticals

Roche announced today it has licensed its P2X3 receptor program aimed at developing first-in-class treatments for chronic pain to Afferent Pharmaceuticals. Afferent was co-founded by Anthony Ford, Ph.D., Pappas Ventures, and Third Rock Ventures, and is focused on developing compounds that treat chronic pain by targeting a novel biological pathway.

16 Dec 2009

HHS to provide H1N1 response update on December 17, 2009

U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius and senior HHS officials leading the H1N1 response at the Department will hold a press conference, at the National Press Club on Thursday, December 17, 2009.

16 Dec 2009

New research building at Children's Hospital of Philadelphia receives LEED certification

Building materials that better retain heat in the winter, and reflect it in the summer; plumbing fixtures that save water; and facilities that encourage employees to bicycle to work. Environmentally-friendly features like these enable the new research building at The Children's Hospital of Philadelphia to be certified as a green structure.

16 Dec 2009

Cancer Research UK's phase I trial results of CHT25 published in Clinical Cancer Research

TWO THIRDS of Hodgkin's lymphoma patients treated with an experimental radioactive cancer therapy responded well to the treatment, reveal the results of a Cancer Research UK phase I trial published in Clinical Cancer Research, today (Tuesday).

16 Dec 2009

DNA reveals earliest proven case of leprosy, Turin Shroud not from Jesus-era Jerusalem

The DNA of a 1st century shrouded man found in a tomb on the edge of the Old City of Jerusalem has revealed the earliest proven case of leprosy. Details of the research will be published December 16 in the PloS ONE Journal.

16 Dec 2009

EU border security market boosted by unauthorised immigration and illegal drug trafficking

European Union (EU) member states are spending more on protecting their borders, which are increasingly subjected to unauthorised immigration and illegal drug trafficking. High investment in advanced technology security and IT-based systems will boost the border security market.

16 Dec 2009

Academics and drug companies must work together to win funds for scientific research, says research director

Academics and drug companies must forge more productive relationships in the face of pressure from politicians and funders for more applied biomedical research, a research director has warned.

16 Dec 2009

Research News and Research

Liberals agitated by compromise, but appear to back health reform

Ivy Foundation awards nearly $10M for new patient-focused brain cancer research projects

Poll: Public cooling to health reform as debate drags on

Tea Party protestors rally against health bills at Capitol protest

Immigrants lose lawsuit against hospital in Atlanta

EMD Serono, Brigham and Women's Hospital collaborate in MS research

Keryx Biopharmaceuticals initiates Phase 3 registration clinical trial for perifosine

Amendment to allow drug importation fails in Senate

Xencor's initiation of novel monoclonal antibody human clinical trial triggers milestone payment from Pfizer

Encouraging early clinical results for treatment of KC with Avedro's Keraflex KXL technology

Reprints Desk signs distribution deals with seven STM journal publishers

First Edition: December 16, 2009

Pomegranate rind, metal salts and Vitamin C: An effective combination for treating MRSA infection

Roche's P2X3 receptor program for chronic pain licensed to Afferent Pharmaceuticals

HHS to provide H1N1 response update on December 17, 2009

New research building at Children's Hospital of Philadelphia receives LEED certification

Cancer Research UK's phase I trial results of CHT25 published in Clinical Cancer Research

DNA reveals earliest proven case of leprosy, Turin Shroud not from Jesus-era Jerusalem

EU border security market boosted by unauthorised immigration and illegal drug trafficking

Academics and drug companies must work together to win funds for scientific research, says research director

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring